Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines

Next Previous
Trial Profile

Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Nov 2018

At a glance

  • Drugs Cobicistat/darunavir (Primary) ; Darunavir (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics

    • Most Recent Events

    • 12 Nov 2018 Planned End Date changed from 1 Sep 2018 to 1 Mar 2019.
    • 12 Nov 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2019.
    • 12 Nov 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top